SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: Skystar Bio-Pharmaceutical Reports 33% Growth in Revenue From

[Skystar Bio-Pharmaceutical Reports 33% Growth in Revenue From Continuing Operations in Second Quarter Fiscal Year 2010 Gross Margin Remains of 53%; $0.33 Diluted Earnings Per Share; Company reiterates fiscal 2010 guidance of $45.5 Million to $47.5 Million XI’AN, CHINA – August 17, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2010 Highlights · Revenue increases]

By | 2016-03-01T05:53:12+00:00 August 17th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

CLNT [Cleantech Solutions International,] 8-K: China Wind Systems, Reports Second Quarter 2010 Results

[China Wind Systems, Reports Second Quarter 2010 Results -- Second quarter 2010 revenuesreased 39.7% to $19.0 million -- Netomereased 69.8% to $3.0 million, or $0.12 per diluted share Press Release CWS News WUXI, Jiangsu, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Wind Systems, (Nasdaq: Second Quarter 2010 Highlights and Recent Events]

By | 2016-02-03T01:16:31+00:00 August 17th, 2010|Categories: Chinese Stocks, CLNT, Webplus ver|Tags: , , , , , |0 Comments
Read More

LONG [eLong,] 6-K: (Original Filing)

[99.1 Press Release issued by the Company on August 16, 2010: “eLong Reports Second Quarter 2010 Unaudited Financial Results” DATED: August 17, 2010 ELONG, INC Mike Doyle Chief Financial Officer eLong Reports Second Quarter 2010 Unaudited Financial Results BEIJING, China — August 16, 2010 — eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited]

By | 2016-03-02T12:23:11+00:00 August 17th, 2010|Categories: Chinese Stocks, LONG, SEC Original|Tags: , , , , , |0 Comments
Read More

LONG [eLong,] 6-K: 99.1 Press Release issued by the Company on

[99.1 Press Release issued by the Company on August 16, 2010: “eLong Reports Second Quarter 2010 Unaudited Financial Results” DATED: August 17, 2010 ELONG, INC Mike Doyle Chief Financial Officer eLong Reports Second Quarter 2010 Unaudited Financial Results BEIJING, China — August 16, 2010 — eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited]

By | 2016-03-02T12:24:02+00:00 August 17th, 2010|Categories: Chinese Stocks, LONG, Webplus ver|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, INC. SECOND QUARTER REVENUE INCREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenue increased 46.4% to $19.4 million - Q2 2010 Non-GAAP adjusted net income increased 50.9% to $5.8 million with adjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and net income]

By | 2016-03-03T14:09:01+00:00 August 17th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

LONG [eLong,] 6-K: (Original Filing)

[99.1 Press Release issued by thempany on August16, 2010: eLong Reports Second Quarter 2010 Unaudited Financial ResultsTED: August 17, 2010 ELONG, Mike Doyle Chief Financial Officer eLong Reports Second Quarter 2010 Unaudited Financial Results BEIJING, China August16, 2010 eLong, (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for]

By | 2016-02-07T01:51:40+00:00 August 17th, 2010|Categories: Chinese Stocks, LONG, SEC Original|Tags: , , , , , |0 Comments
Read More

GAME [Shanda Games] 6-K: Shanda Games Expresses Deep Condolences to Gansu Landslide

[Shanda Games Expresses Deep Condolences to Gansu Landslide Victims; Game Services Suspended for One Day SHANGHAI, China, Aug 16, 2010 (GlobeNewswire via COMTEX News Network) — Shanda Games Limited (“Shanda Games,” or the “Company”) (Nasdaq:GAME), a leading online game developer, operator and publisher in China, today announced that in accordance with a public notice issued by the Chinese government on] [FORM 6-K Shanda Games Limited No. 1 Office Building Form 20-F Form 40-F. þ o Form 20-F Regulation S-T o Rule 101(b)(1): Regulation S-T o Rule 101(b)(7): Rule 12g3-2(b) o þ Yes Rule 12g3-2(b): 82- Shanda Games Limited Tan Qunzhao Chief executive officer Description Shanda Games Expresses Deep Condolences to Gansu Landslide Victims; Game Services Suspended for One Day 6-K]

By | 2016-03-16T05:43:48+00:00 August 17th, 2010|Categories: Chinese Stocks, GAME, Webplus ver|Tags: , , , , , |0 Comments
Read More

LONG [eLong,] 6-K: 99.1 Press Release issued by thempany on August16,

[99.1 Press Release issued by thempany on August16, 2010: eLong Reports Second Quarter 2010 Unaudited Financial ResultsTED: August 17, 2010 ELONG, Mike Doyle Chief Financial Officer eLong Reports Second Quarter 2010 Unaudited Financial Results BEIJING, China August16, 2010 eLong, (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for]

By | 2016-02-07T01:53:11+00:00 August 17th, 2010|Categories: Chinese Stocks, LONG, Webplus ver|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited Second Quarter 2010 Financial Results - Conference call scheduled for Monday, August 16, 2010 at 8:00 AM EDT — Beijing — August 16, 2010 — Sinovac Biotech Ltd. ( NASDAQ: SVA), a leading China-based vaccine manufacturer , announced today its un audited financial results for the three-month and six-month periods ended June 30, 2010. Financial Highlights ·] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]

By | 2016-03-24T02:45:23+00:00 August 17th, 2010|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, SECOND QUARTER REVENUEREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenuereased 46.4% to $19.4 million - Q2 2010 Non-GAAPjusted netomereased 50.9% to $5.8 million withjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and netome between $18.0 to]

By | 2016-02-07T16:54:40+00:00 August 17th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar